BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 24072348)

  • 1. Multimodality imaging of an unusual case of cardiac paraganglioma.
    Thomas D; Grant FD; Kwong R; Nose V; Di Carli MF; Dorbala S
    J Nucl Cardiol; 2009; 16(4):644-7. PubMed ID: 19266248
    [No Abstract]   [Full Text] [Related]  

  • 2. (Radio)Theranostic Patient Management in Oncology Exemplified by Neuroendocrine Neoplasms, Prostate Cancer, and Breast Cancer.
    Velikyan I
    Pharmaceuticals (Basel); 2020 Mar; 13(3):. PubMed ID: 32151049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET/Computed Tomography in Neuroendocrine Tumor: Value to Patient Management and Survival Outcomes.
    Shamim SA; Kumar A; Kumar R
    PET Clin; 2015 Jul; 10(3):411-21. PubMed ID: 26099675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient selection for personalized peptide receptor radionuclide therapy using Ga-68 somatostatin receptor PET/CT.
    Kulkarni HR; Baum RP
    PET Clin; 2014 Jan; 9(1):83-90. PubMed ID: 25029937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Could 68Ga-somatostatin analogues replace other PET tracers in evaluating extra-adrenal paragangliomas?
    Treglia G; Giovanella L
    Eur J Nucl Med Mol Imaging; 2013 Dec; 40(12):1797-9. PubMed ID: 24072348
    [No Abstract]   [Full Text] [Related]  

  • 6. Multifocal extra-adrenal paraganglioma evaluated with different PET tracers: comparison between 18F-FDG, 18F-DOPA and 68Ga DOTANOC PET/CT.
    Treglia G; Cardillo G; Stefanelli A; Di Franco D; Enang GN; Giordano A; Rufini V
    Clin Nucl Med; 2013 Dec; 38(12):e458-62. PubMed ID: 23486329
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Kroiss AS; Uprimny C; Shulkin BL; Gruber L; Frech A; Url C; Riechelmann H; Sprinzl GM; Thomé C; Treglia G; Kjaer A; Fraedrich G; Virgolini IJ
    Nucl Med Biol; 2019 Apr; 71():47-53. PubMed ID: 31152973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-DOPA PET/CT but not 68Ga-DOTA-TOC PET/CT revealed the underlying cause of ectopic Cushing syndrome.
    Schalin-Jäntti C; Ahonen A; Seppänen M
    Clin Nucl Med; 2012 Sep; 37(9):904-5. PubMed ID: 22889786
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Kroiss AS; Uprimny C; Shulkin BL; Gruber L; Frech A; Jazbec T; Girod PP; Url C; Thomé C; Riechelmann H; Sprinzl GM; Fraedrich G; Virgolini IJ
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(2):94-99. PubMed ID: 30630744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective comparison between 68Ga-DOTA-TOC PET/CT and 18F-DOPA PET/CT in patients with extra-adrenal paraganglioma.
    Kroiss A; Putzer D; Frech A; Decristoforo C; Uprimny C; Gasser RW; Shulkin BL; Url C; Widmann G; Prommegger R; Sprinzl GM; Fraedrich G; Virgolini IJ
    Eur J Nucl Med Mol Imaging; 2013 Dec; 40(12):1800-8. PubMed ID: 24072345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatostatin receptor PET/CT in neuroendocrine tumours: update on systematic review and meta-analysis.
    Geijer H; Breimer LH
    Eur J Nucl Med Mol Imaging; 2013 Oct; 40(11):1770-80. PubMed ID: 23873003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of metaiodobenzylguanidine scintigraphy with positron emission tomography in the diagnostic work-up of pheochromocytoma and paraganglioma: a systematic review.
    Rufini V; Treglia G; Castaldi P; Perotti G; Giordano A
    Q J Nucl Med Mol Imaging; 2013 Jun; 57(2):122-33. PubMed ID: 23822989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gallium-68 DOTANOC imaging in paraganglioma/pheochromocytoma: presentation of sample cases and review of the literature.
    Lopci E; Zanoni L; Fanti S; Ambrosini V; Castellani MR; Aktolun C; Chiti A
    Q J Nucl Med Mol Imaging; 2013 Jun; 57(2):134-45. PubMed ID: 23598686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 68Ga-DOTANOC PET/CT for baseline evaluation of patients with head and neck paraganglioma.
    Sharma P; Thakar A; Suman K C S; Dhull VS; Singh H; Naswa N; Reddy RM; Karunanithi S; Kumar R; Kumar R; Malhotra A; Bal C
    J Nucl Med; 2013 Jun; 54(6):841-7. PubMed ID: 23520216
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.